226 related articles for article (PubMed ID: 26848503)
1. Mapping and Exploring the Collagen-I Proteostasis Network.
DiChiara AS; Taylor RJ; Wong MY; Doan ND; Rosario AM; Shoulders MD
ACS Chem Biol; 2016 May; 11(5):1408-21. PubMed ID: 26848503
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of proteostasis defects caused by osteogenesis imperfecta mutations in the collagen-α2(I) C-propeptide domain.
Doan ND; Hosseini AS; Bikovtseva AA; Huang MS; DiChiara AS; Papa LJ; Koller A; Shoulders MD
J Biol Chem; 2020 Jul; 295(29):9959-9973. PubMed ID: 32482890
[TBL] [Abstract][Full Text] [Related]
3. Targeting defective proteostasis in the collagenopathies.
Wong MY; Shoulders MD
Curr Opin Chem Biol; 2019 Jun; 50():80-88. PubMed ID: 31028939
[TBL] [Abstract][Full Text] [Related]
4. Mass Spectrometry-Based Proteomics to Define Intracellular Collagen Interactomes.
Doan ND; DiChiara AS; Del Rosario AM; Schiavoni RP; Shoulders MD
Methods Mol Biol; 2019; 1944():95-114. PubMed ID: 30840237
[TBL] [Abstract][Full Text] [Related]
5. Revealing functional insights into ER proteostasis through proteomics and interactomics.
Wright MT; Plate L
Exp Cell Res; 2021 Feb; 399(1):112417. PubMed ID: 33301765
[TBL] [Abstract][Full Text] [Related]
6. Proteostasis: bad news and good news from the endoplasmic reticulum.
Noack J; Brambilla Pisoni G; Molinari M
Swiss Med Wkly; 2014; 144():w14001. PubMed ID: 25144910
[TBL] [Abstract][Full Text] [Related]
7. Chaperoning osteogenesis: new protein-folding disease paradigms.
Makareeva E; Aviles NA; Leikin S
Trends Cell Biol; 2011 Mar; 21(3):168-76. PubMed ID: 21183349
[TBL] [Abstract][Full Text] [Related]
8. Alpha 1-Antitrypsin Deficiency: A Disorder of Proteostasis-Mediated Protein Folding and Trafficking Pathways.
Karatas E; Bouchecareilh M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098273
[TBL] [Abstract][Full Text] [Related]
9. Chemical and/or biological therapeutic strategies to ameliorate protein misfolding diseases.
Ong DS; Kelly JW
Curr Opin Cell Biol; 2011 Apr; 23(2):231-8. PubMed ID: 21146391
[TBL] [Abstract][Full Text] [Related]
10. Proteostasis strategies for restoring alpha1-antitrypsin deficiency.
Bouchecareilh M; Conkright JJ; Balch WE
Proc Am Thorac Soc; 2010 Nov; 7(6):415-22. PubMed ID: 21030523
[TBL] [Abstract][Full Text] [Related]
11. Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases: progress and prognosis.
Lindquist SL; Kelly JW
Cold Spring Harb Perspect Biol; 2011 Dec; 3(12):. PubMed ID: 21900404
[TBL] [Abstract][Full Text] [Related]
12. Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.
Marinko JT; Huang H; Penn WD; Capra JA; Schlebach JP; Sanders CR
Chem Rev; 2019 May; 119(9):5537-5606. PubMed ID: 30608666
[TBL] [Abstract][Full Text] [Related]
13. Protein folding, misfolding, aggregation and their implications in human diseases: discovering therapeutic ways to amyloid-associated diseases.
Iram A; Naeem A
Cell Biochem Biophys; 2014 Sep; 70(1):51-61. PubMed ID: 24639112
[TBL] [Abstract][Full Text] [Related]
14. Proteomics uncovering possible key players in F508del-CFTR processing and trafficking.
Gomes-Alves P; Penque D
Expert Rev Proteomics; 2010 Aug; 7(4):487-94. PubMed ID: 20653505
[TBL] [Abstract][Full Text] [Related]
15. Misfolded proteins and retinal dystrophies.
Lin JH; Lavail MM
Adv Exp Med Biol; 2010; 664():115-21. PubMed ID: 20238009
[TBL] [Abstract][Full Text] [Related]
16. Defective cellular trafficking of the bone morphogenetic protein receptor type II by mutations underlying familial pulmonary arterial hypertension.
John A; Kizhakkedath P; Al-Gazali L; Ali BR
Gene; 2015 Apr; 561(1):148-56. PubMed ID: 25688877
[TBL] [Abstract][Full Text] [Related]
17. Non-enzymatic post-translational protein modifications and proteostasis network deregulation in carcinogenesis.
Trougakos IP; Sesti F; Tsakiri E; Gorgoulis VG
J Proteomics; 2013 Oct; 92():274-98. PubMed ID: 23500136
[TBL] [Abstract][Full Text] [Related]
18. Proteostasis impairment in protein-misfolding and -aggregation diseases.
Hipp MS; Park SH; Hartl FU
Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
[TBL] [Abstract][Full Text] [Related]
19. Molecular chaperones as therapeutic targets to counteract proteostasis defects.
Cattaneo M; Dominici R; Cardano M; Diaferia G; Rovida E; Biunno I
J Cell Physiol; 2012 Mar; 227(3):1226-34. PubMed ID: 21618531
[TBL] [Abstract][Full Text] [Related]
20. Molecular chaperone functions in protein folding and proteostasis.
Kim YE; Hipp MS; Bracher A; Hayer-Hartl M; Hartl FU
Annu Rev Biochem; 2013; 82():323-55. PubMed ID: 23746257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
